Search Results - "Hecking, M."

Proceedings From an International Consensus Meeting on Posttransplantation Diabetes Mellitus: Recommendations and Future Directions by Sharif, A., Hecking, M., de Vries, A. P. J., Porrini, E., Hornum, M., Rasoul‐Rockenschaub, S., Berlakovich, G., Krebs, M., Kautzky‐Willer, A., Schernthaner, G., Marchetti, P., Pacini, G., Ojo, A., Takahara, S., Larsen, J. L., Budde, K., Eller, K., Pascual, J., Jardine, A., Bakker, S. J. L., Valderhaug, T. G., Jenssen, T. G., Cohney, S., Säemann, M. D.

“…A consensus meeting was held in Vienna on September 8–9, 2013, to discuss diagnostic and therapeutic challenges surrounding development of diabetes mellitus…”
Get full text

The Multifunctional Role of mTOR in Innate Immunity: Implications for Transplant Immunity by Säemann, M. D., Haidinger, M., Hecking, M., Hörl, W. H., Weichhart, T.

“…The mammalian target of rapamycin (mTOR) is an evolutionary conserved serine–threonine kinase that senses various environmental stimuli in most cells primarily…”
Get full text

Efficacy and Safety of Vildagliptin in New‐Onset Diabetes After Kidney Transplantation—A Randomized, Double‐Blind, Placebo‐Controlled Trial by Haidinger, M., Werzowa, J., Hecking, M., Antlanger, M., Stemer, G., Pleiner, J., Kopecky, C., Kovarik, J. J., Döller, D., Pacini, G., Säemann, M. D.

“…New‐onset diabetes after transplantation (NODAT) is a serious complication after kidney transplantation, but therapeutic strategies remain underexplored…”
Get full text

Camostat Mesylate Versus Lopinavir/Ritonavir in Hospitalized Patients With COVID-19-Results From a Randomized, Controlled, Open Label, Platform Trial (ACOVACT) by Karolyi, M, Pawelka, E, Omid, S, Koenig, F, Kauer, V, Rumpf, B, Hoepler, W, Kuran, A, Laferl, H, Seitz, T, Traugott, M, Rathkolb, V, Mueller, M, Abrahamowicz, A, Schoergenhofer, C, Hecking, M, Assinger, A, Wenisch, C, Zeitlinger, M, Jilma, B, Zoufaly, A

“…To date, no oral antiviral drug has proven to be beneficial in hospitalized patients with COVID-19. In this randomized, controlled, open-label, platform trial,…”
Get full text

CMV Late Phase‐Induced mTOR Activation Is Essential for Efficient Virus Replication in Polarized Human Macrophages by Poglitsch, M., Weichhart, T., Hecking, M., Werzowa, J., Katholnig, K., Antlanger, M., Krmpotic, A., Jonjic, S., Hörl, W. H., Zlabinger, G. J., Puchhammer, E., Säemann, M. D.

“…Human cytomegalovirus (CMV) remains one of the most important pathogens following solid‐organ transplantation. Mounting evidence indicates that mammalian…”
Get full text

The Diagnosis of Posttransplantation Diabetes Mellitus: Meeting the Challenges by Werzowa, J., Hecking, M., Haidinger, M., Döller, D., Sharif, A., Tura, A., Säemann, M. D.

“…Posttransplantation diabetes mellitus (PTDM) is a major complication after renal transplantation due to its negative impact on patient and graft survival, and…”
Get full text

Late onset Pneumocystis pneumonia in renal transplantation after long‐term immunosuppression with belatacept by Haidinger, M., Hecking, M., Memarsadeghi, M., Weichhart, T., Werzowa, J., Hörl, W.H., Säemann, M.D.

“…: Interference with T‐cell function increases the risk of infections, especially during the early post‐transplant period. Belatacept, a costimulation blocker,…”
Get full text

Ksp-cadherin is a functional cell–cell adhesion molecule related to LI-cadherin by Wendeler, M.W, Praus, M, Jung, R, Hecking, M, Metzig, C, Geßner, R

“…Ksp- and LI-cadherin are structurally homologous proteins coexpressed with E-cadherin in renal and intestinal epithelia, respectively. Whereas LI-cadherin has…”
Get full text

Sex and gender differences in chronic kidney disease: progression to end-stage renal disease and haemodialysis by Cobo, Gabriela, Hecking, Manfred, Port, Friedrich K, Exner, Isabella, Lindholm, Bengt, Stenvinkel, Peter, Carrero, Juan Jesús

“…Sex and gender differences are of fundamental importance in most diseases, including chronic kidney disease (CKD). Men and women with CKD differ with regard to…”
Get more information

Sex Differences in the Recognition, Monitoring, and Management of CKD in Health Care: An Observational Cohort Study by Swartling, Oskar, Yang, Yuanhang, Clase, Catherine M, Fu, Edouard L, Hecking, Manfred, Hödlmoser, Sebastian, Trolle-Lagerros, Ylva, Evans, Marie, Carrero, Juan J

“…Reported sex differences in the etiology, population prevalence, progression rates, and health outcomes of people with CKD may be explained by differences in…”
Get full text

Differences in the epidemiology, management and outcomes of kidney disease in men and women by Chesnaye, Nicholas C., Carrero, Juan Jesus, Hecking, Manfred, Jager, Kitty J.

“…Improved understanding of differences in kidney disease epidemiology, management and outcomes in men and women could help nephrologists to better meet the…”
Get full text

Perspectives of Nephrologists on Gender Disparities in Access to Kidney Transplantation by Natale, Patrizia, Hecking, Manfred, Kurnikowski, Amelie, Scholes-Robertson, Nicole, Carrero, Juan Jesus, Wong, Germaine, Strippoli, Giovanni, Jaure, Allison

“…Gender disparities in access to kidney transplantation are apparent, with women being up to 20% less likely to receive kidney transplant compared with men…”
Get full text

INTRADIALYTIC INFUSION OF DIALYSATE BOLUS FOR THE ESTIMATION OF ABSOLUTE BLOOD VOLUME IN HAEMODIALYSIS PATIENTS by Pstras, L, Krenn, S, Waniewski, J, Schmiedecker, M, Mussnig, S, Niknam, J, Wabel, P, Mayer, C, Schneditz, D, Hecking, M

“…Objectives: A relatively simple method has recently been proposed for the estimation of absolute blood volume (ABV) in haemodialysis (HD) patients, which…”
Get full text

Chronic Kidney Disease, Gender, and Access to Care: A Global Perspective by Carrero, Juan-Jesus, Hecking, Manfred, Ulasi, Ifeoma, Sola, Laura, Thomas, Bernadette

“…Little is known regarding the ways in which chronic kidney disease (CKD) prevalence and progression differ between the sexes. Still less is known regarding how…”
Get full text

The Other Way Around: Living With Chronic Kidney Disease From the Perspective of Men by Hecking, Manfred, Hödlmoser, Sebastian, Ahmed, Sofia B., Carrero, Juan Jesus

“…A wealth of evidence has suggested sex (biological) and gender (sociocultural) differences in the prevalence, progression, and outcomes of persons with chronic…”
Get full text

Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease by Carrero, Juan Jesus, Hecking, Manfred, Chesnaye, Nicholas C., Jager, Kitty J.

“…Key Points The proportion of women with predialysis chronic kidney disease (CKD) is higher than that of men; this difference is likely due to the longer life…”
Get full text

Country-specific sex disparities in living kidney donation by Kurnikowski, Amelie, Krenn, Simon, Lewandowski, Michal J, Schwaiger, Elisabeth, Tong, Allison, Jager, Kitty J, Carrero, Juan Jesus, Hecking, Manfred, Hödlmoser, Sebastian

Get full text

Sex differences in chronic kidney disease awareness among US adults, 1999 to 2018 by Hödlmoser, Sebastian, Winkelmayer, Wolfgang C, Zee, Jarcy, Pecoits-Filho, Roberto, Pisoni, Ronald L, Port, Friedrich K, Robinson, Bruce M, Ristl, Robin, Krenn, Simon, Kurnikowski, Amelie, Lewandowski, Michał, Ton, Allison, Carrero, Juan Jesus, Schernhammer, Eva S, Hecking, Manfred

“…Chronic kidney disease (CKD) is less prevalent among men than women, but more men than women initiate kidney replacement therapy. Differences in CKD awareness…”
Get full text

Sex Differences in Kidney Replacement Therapy Initiation and Maintenance by Antlanger, Marlies, Noordzij, Marlies, van de Luijtgaarden, Moniek, Carrero, Juan Jesus, Palsson, Runolfur, Finne, Patrik, Hemmelder, Marc H, Aresté-Fosalba, Nuria, Reisæter, Anna Varberg, Cases, Aleix, Traynor, Jamie P, Kramar, Reinhard, Massy, Ziad, Jager, Kitty J, Hecking, Manfred

“…More men than women undergo kidney replacement therapy (KRT) despite a larger number of women being affected by CKD. The aim of this multinational European…”
Get full text

Vildagliptin and pioglitazone in patients with impaired glucose tolerance after kidney transplantation: a randomized, placebo-controlled clinical trial by Werzowa, Johannes, Hecking, Manfred, Haidinger, Michael, Lechner, Felix, Döller, Dominik, Pacini, Giovanni, Stemer, Gunar, Pleiner, Johannes, Frantal, Sophie, Säemann, Marcus D

“…New-onset diabetes after transplantation (NODAT) is a serious complication after kidney transplantation affecting graft and patient survival. Currently, no…”
Get full text